J. Soutschek, A. Akinc, B. Bramlage, C. K. Constien, R. Donoghue et al., Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs, Nature, vol.52, issue.7014, pp.432173-178, 2004.
DOI : 10.1038/nature03121

P. Shankar, N. Manjunath, and J. Lieberman, The Prospect of Silencing Disease Using RNA Interference, JAMA, vol.293, issue.11, pp.1367-1373, 2005.
DOI : 10.1001/jama.293.11.1367

K. Howard, Delivery of RNA interference therapeutics using polycation-based nanoparticles, Advanced Drug Delivery Reviews, vol.61, issue.9, pp.710-720, 2009.
DOI : 10.1016/j.addr.2009.04.001

D. Chang, C. Fung, W. Ou, P. Chao, S. Li et al., Self-assembly of the JC virus major capsid protein, VP1, expressed in insect cells., Journal of General Virology, vol.78, issue.6, pp.781435-1439, 1997.
DOI : 10.1099/0022-1317-78-6-1435

M. Wang, T. Tsou, L. Chen, W. Ou, P. Chen et al., Inhibition of Simian Virus 40 Large Tumor Antigen Expression in Human Fetal Glial Cells by an Antisense Oligodeoxynucleotide Delivered by the JC Virus-Like Particle, Human Gene Therapy, vol.15, issue.11, pp.151077-1090, 2004.
DOI : 10.1089/hum.2004.15.1077

C. Goldmann, N. Stolte, T. Nisslein, G. Hunsmann, W. Luke et al., Packaging of small molecules into VP1-virus-like particles of the human polyomavirus JC virus, Journal of Virological Methods, vol.90, issue.1, pp.85-90, 2000.
DOI : 10.1016/S0166-0934(00)00226-3

E. Hagiwara, M. Gourley, S. Lee, and D. Klinman, Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio Received, p.24, 2010.

L. Llorente, Y. Richaud-patin, R. Fior, J. Alcocer-varela, J. Wijdenes et al., In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity, Arthritis Rheum, issue.11, pp.371647-1655, 1994.

L. Llorente, Y. Richaud-patin, C. Garcia-padilla, E. Claret, J. Jakez-ocampo et al., Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus, Arthritis & Rheumatism, vol.104, issue.8, pp.431790-1800, 2000.
DOI : 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2

Z. Yin, G. Bahtiyar, N. Zhang, L. Liu, P. Zhu et al., IL-10 Regulates Murine Lupus, The Journal of Immunology, vol.169, issue.4, pp.2148-2155, 2002.
DOI : 10.4049/jimmunol.169.4.2148

H. Ishida, T. Muchamuel, S. Sakaguchi, S. Andrade, S. Menon et al., Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice, Journal of Experimental Medicine, vol.179, issue.1, pp.305-310, 1994.
DOI : 10.1084/jem.179.1.305

P. Chen, M. Wang, W. Ou, C. Lii, L. Chen et al., Disulfide bonds stabilize JC virus capsid-like structure by protecting calcium ions from chelation, FEBS Letters, vol.207, issue.3, pp.109-113, 2001.
DOI : 10.1016/S0014-5793(01)02598-4

URL : http://ir.lib.csmu.edu.tw:8080/ir/bitstream/310902500/11106/2/index.html

J. Chang, An economic and efficient method of RNAi vector constructions, Analytical Biochemistry, vol.334, issue.1, pp.199-200, 2004.
DOI : 10.1016/j.ab.2004.07.018

W. Ou, M. Wang, C. Fung, R. Tsai, P. Chao et al., The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells., Journal of General Virology, vol.80, issue.1, pp.8039-8085, 1999.
DOI : 10.1099/0022-1317-80-1-39

L. Chen, M. Wang, W. Ou, C. Fung, P. Chen et al., Efficient gene transfer using the human JC virus-like particle that inhibits human colon adenocarcinoma growth in a nude mouse model, Gene Therapy, vol.70, issue.8, p.50, 2010.
DOI : 10.1074/jbc.M409326200

S. Suzuki, H. Sawa, R. Komagome, Y. Orba, M. Yamada et al., Broad Distribution of the JC Virus Receptor Contrasts with a Marked Cellular Restriction of Virus Replication, Virology, vol.286, issue.1, pp.100-112, 2001.
DOI : 10.1006/viro.2001.0972

K. Moore, O. Garra, A. De-waal-malefyt, R. Vieira, P. Mosmann et al., Interleukin-10, Annual Review of Immunology, vol.11, issue.1, pp.165-190, 1993.
DOI : 10.1146/annurev.iy.11.040193.001121

P. Durez, D. Abramowicz, C. Gerard, M. Van-mechelen, Z. Amraoui et al., In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A, Journal of Experimental Medicine, vol.177, issue.2, pp.551-555, 1993.
DOI : 10.1084/jem.177.2.551

A. Marchant, C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gerard et al., Interleukin-10 controls interferon-?? and tumor necrosis factor production during experimental endotoxemia, European Journal of Immunology, vol.61, issue.5, pp.1167-1171, 1994.
DOI : 10.1002/eji.1830240524

URL : https://biblio.ugent.be/doc/api

M. Howard, T. Muchamuel, S. Andrade, and S. Menon, Interleukin 10 protects mice from lethal endotoxemia, Journal of Experimental Medicine, vol.177, issue.4, pp.1205-1208, 1993.
DOI : 10.1084/jem.177.4.1205

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190971

D. Berg, R. Kuhn, K. Rajewsky, W. Muller, S. Menon et al., Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance., Journal of Clinical Investigation, vol.96, issue.5, pp.962339-2347, 1995.
DOI : 10.1172/JCI118290

F. Lauw, D. Pajkrt, C. Hack, M. Kurimoto, S. Van-deventer et al., Proinflammatory Effects of IL-10 During Human Endotoxemia, The Journal of Immunology, vol.165, issue.5, pp.2783-2789, 2000.
DOI : 10.4049/jimmunol.165.5.2783

T. Kaneko, M. Itoh, Y. Nakamura, A. Iimura, S. Hayashi et al., Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis, Cytokine, vol.22, issue.1-2, pp.50-53, 2003.
DOI : 10.1016/S1043-4666(03)00103-0

. Chou, In vitro and in vivo targeted delivery of IL-10 interfering RNA by JC virus-like particles, Journal of Biomedical Science, vol.17, issue.1, p.51, 2010.
DOI : 10.1186/1423-0127-17-51

URL : https://hal.archives-ouvertes.fr/inserm-00663735